Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Video
Emerging Psychedelic Therapies
Author(s):
Here's why psychedelics might be a valuable addition to mental health treatment.
Video Player is loading.
Alexander Somjen discusses the fragmented psychedelic industry, regulatory frameworks, and potential commercial success.
Alexander Somjen is the CEO and Director of Origin Therapeutics.
Related Videos
Innovation and Failure in Developing New Psychiatric Treatments
Dennis S. Charney, MD, Discusses the Last 40 Years in Psychiatry and Shares his Hopes for the Future
MM120 Shows Rapid and Lasting Anxiety Reduction in Phase 3 Generalized Anxiety Disorder Trials
FDA Breakthrough Therapy Designation and the Future of MM120
MindMed's Phase 3 Trials of MM120 for Generalized Anxiety Disorder Underway
How Experience With Addiction Informs Patient Treatment
What Does the Future of Addiction Treatment Look Like?
The Importance of Early Intervention of Addiction and Harm Reduction
Struggles with Alcoholism: A Journey from Denial to Recovery
The Gold Standard in Addiction Treatment
Related Content
